NICE technology appraisal

for Hybrid Closed Loop systems

NICE now recommends Hybrid Closed Loop (HCL) systems for selected people with type 1 diabetes1

The new NICE technology appraisal recommendation means more people with type 1 diabetes qualify for a Hybrid Closed (HCL) compatible CGM system

 

NICE guidelines for HCL

NICE recommends HCL1 as an option for managing blood glucose levels in type 1 diabetes in:

  • Adults with HbA1c ≥7.5% (58mmol/mol), or who have disabling hypoglycaemic episodes despite continuous subcutaneous insulin (CSII), real-time continuous glucose monitoring (rtCGM) or intermittently scanned CGM (isCGM)

  • Children and young people

  • Those who are pregnant or are planning pregnancy

Woman wearing a FreeStyle Libre sensor and an HCP

Benefits of HCL systems1,2

Improved HbA1c

Increased Time in Range

Reduced hypoglycaemia

Reduced diabetes distress

Improved quality of life

FreeStyle Libre Systems & Partnerships

All together, easier diabetes management through intentional partnerships

Libre is intentionally building partnerships to create one easy, cohesive experience, no matter what partner products you use. Get Automated insulin delivery using the accurate, minute-to-minute readings from your Libre 3 Plus sensor.2

 

FreeStyle Libre 3 Plus logo

Minute-to-minute glucose readings from Libre 3 Plus sensor combined with the mylife YpsoPump insulin pump and mylife CamAPS FX app — for easier3 diabetes management4

 

mylife loop AID
FreeStyle Libre 2 Plus logo

Our 15-day sensor and Omnipod 5 Automated Insulin Delivery System (AID) create one easy5, integrated experience for you

OmniPod & FreeStyle Libre 2 Plus

References & Disclaimers

Images are for illustrative purposes only. Not real patient or data. 

The sensor housing, FreeStyle, Libre, and related brand marks are marks of Abbott. Mylife and YpsoPump are registered trademarks of Ypsomed AG. CamAPS is a registered trademark of CamDiab Ltd. Omnipod and the Omnipod logo are registered trademarks of Insulet Corporation and used with permission. Other trademarks are the property of their respective owners. 

1. NICE technology appraisal guidance TA943 (2023). Available at https://www.nice.org.uk/guidance/ta943.

2. Crabtree TSJ, Griffin TP, Yap YW, Narendran P, Gallen G, Furlong N, Cranston I, Chakera A, Philbey C, Karamat MA, Saraf S, Kamaruddin S, Gurnell E, Chapman A, Hussain S, Elliott J, Leelarathna L, Ryder REJ, Hammond P, Lumb A, Choudhary P, Wilmot EG; ABCD Closed-Loop Audit Contributors. Hybrid Closed-Loop Therapy in Adults With Type 1 Diabetes and Above-Target HbA1c: A Real-world Observational Study. Diabetes Care. 2023 Oct 1;46(10):1831-1838. doi: 10.2337/dc23-0635. PMID: 37566697; PMCID: PMC10516256.

3. Based on product features including up to 15 day wear period, automatic readings every minute, accuracy data, and single-app setup with AID systems.

4. FreeStyle Libre 3 system is authorised to work with the mylife Loop automated insulin delivery system, including the mylife CamAPS FX app and mylife YpsoPump insulin pump. For use of FreeStyle Libre 3 and FreeStyle Libre 3 Plus sensor with the mylife Loop, refer to the labeling provided with the mylife CamAPS FX app.

5. Based on product features including up to 15-day wear period, accuracy data, and single-app setup with AID systems.

 

ADC-84010 v4.0

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Butterfly-loader-image